These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 17204507

  • 1. Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma: Kitasato Gynecologic Radiation Oncology Group (KGROG 0501).
    Niibe Y, Hayakawa K, Tsunoda S, Kanai T, Imai M, Arai M, Arai T, Kawaguchi M, Jobo T, Hamada Y, Yago K, Unno N, Kitasato Gynecologic Radiation Oncology Group.
    Jpn J Clin Oncol; 2007 Jan; 37(1):70-2. PubMed ID: 17204507
    [Abstract] [Full Text] [Related]

  • 2. Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)--initial analysis.
    Niibe Y, Tsunoda S, Jobo T, Imai M, Matsuo K, Matsunaga K, Unno N, Hayakawa K.
    Eur J Gynaecol Oncol; 2008 Jan; 29(3):222-4. PubMed ID: 18592783
    [Abstract] [Full Text] [Related]

  • 3. A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study.
    Yokoyama Y, Takano T, Nakahara K, Shoji T, Sato H, Yamada H, Yaegashi N, Okamura K, Kurachi H, Sugiyama T, Tanaka T, Sato A, Tase T, Mizunuma H.
    Oncol Rep; 2008 Jun; 19(6):1551-6. PubMed ID: 18497964
    [Abstract] [Full Text] [Related]

  • 4. Cervical cancer: combined modality therapy.
    Grigsby PW.
    Cancer J; 2001 Jun; 7 Suppl 1():S47-50. PubMed ID: 11504285
    [Abstract] [Full Text] [Related]

  • 5. Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
    Sakata K, Sakurai H, Suzuki Y, Katoh S, Ohno T, Toita T, Kataoka M, Tanaka E, Kaneyasu Y, Uno T, Harima Y, Nakano T, Japan Radiation Oncology Study Group.
    Acta Oncol; 2008 Jun; 47(3):434-41. PubMed ID: 18348003
    [Abstract] [Full Text] [Related]

  • 6. Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix.
    Yoshinaga K, Niikura H, Ogawa Y, Nemoto K, Nagase S, Takano T, Ito K, Yaegashi N.
    Gynecol Oncol; 2007 Jan; 104(1):36-40. PubMed ID: 16889822
    [Abstract] [Full Text] [Related]

  • 7. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA, Tewari KS, Shah A, Brewster WR, Burger RA, Kuo JV, Monk BJ.
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [Abstract] [Full Text] [Related]

  • 8. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F, Cojocariu OM, Levy P, Lefranc JP, Darai E, Jannet D, Ansquer Y, Lhuillier PE, Benifla JL, Seince N, Touboul E.
    Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1508-15. PubMed ID: 18676093
    [Abstract] [Full Text] [Related]

  • 9. Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer.
    Adachi S, Ogasawara T, Tsubamoto H, Oku H, Hori Y, Tsuji Y, Takemura T, Koyama K.
    Int J Clin Pharmacol Res; 2001 Dec 01; 21(3-4):105-10. PubMed ID: 12067139
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Risk stratification for failure in patients with advanced cervical cancer after concurrent chemoradiotherapy: another way to optimise treatment results.
    Liang JA, Chen SW, Chang WC, Hung YC, Yeh LS, Yang SN, Lin FJ.
    Clin Oncol (R Coll Radiol); 2008 Nov 01; 20(9):683-90. PubMed ID: 18676129
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
    Parker K, Gallop-Evans E, Hanna L, Adams M.
    Int J Radiat Oncol Biol Phys; 2009 May 01; 74(1):140-6. PubMed ID: 18922646
    [Abstract] [Full Text] [Related]

  • 14. [Concurrent chemoradiation therapy with nedaplatin for high-risk cervical cancer--clinical investigation of adverse events].
    Kamiura S, Kobayashi K, Ohira H, Seino H, Hashimoto N, Sawai K, Samejima Y, Saji F.
    Gan To Kagaku Ryoho; 2001 Jul 01; 28(7):979-86. PubMed ID: 11478148
    [Abstract] [Full Text] [Related]

  • 15. [Concurrent weekly nedaplatin-based radiotherapy for high risk, recurrent and advanced cervical cancer].
    Idei T, Sakamoto H, Nakajima Y, Hiraiwa Y, Takami N, Chishima F, Ohtani K, Nagaishi M, Yamamoto T, Kawamori J, Himi K, Tanaka Y.
    Gan To Kagaku Ryoho; 2003 Apr 01; 30(4):505-9. PubMed ID: 12722682
    [Abstract] [Full Text] [Related]

  • 16. Intraarterial cisplatin/nedaplatin and intravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer.
    Kawase S, Okuda T, Ikeda M, Ishihara S, Itoh Y, Yanagawa S, Ishigaki T.
    Gynecol Oncol; 2006 Sep 01; 102(3):493-9. PubMed ID: 16478629
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer.
    Novetsky AP, Einstein MH, Goldberg GL, Hailpern SM, Landau E, Fields AL, Mutyala S, Kalnicki S, Garg M.
    Gynecol Oncol; 2007 Jun 01; 105(3):635-40. PubMed ID: 17331568
    [Abstract] [Full Text] [Related]

  • 19. Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity.
    Delpech Y, Haie-Meder C, Rey A, Zafrani Y, Uzan C, Gouy S, Pautier P, Lhommé C, Duvillard P, Castaigne D, Morice P.
    Ann Surg Oncol; 2007 Nov 01; 14(11):3223-31. PubMed ID: 17713822
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.